Literature DB >> 29064469

Movement disorders: Patients with spinocerebellar ataxia 38 benefit from DHA supplementation.

Heather Wood.   

Abstract

Entities:  

Year:  2017        PMID： 29064469     DOI： 10.1038/nrneurol.2017.154

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38.

Authors:  Marta Manes; Antonella Alberici; Eleonora Di Gregorio; Loredana Boccone; Enrico Premi; Nico Mitro; Maria Pia Pasolini; Claudia Pani; Barbara Paghera; Daniela Perani; Laura Orsi; Chiara Costanzi; Marta Ferrero; Adele Zoppo; Filippo Tempia; Donatella Caruso; Mario Grassi; Alessandro Padovani; Alfredo Brusco; Barbara Borroni
Journal:  Ann Neurol       Date:  2017-10-22       Impact factor: 11.274
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.